Cargando…
Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type
Extranodal NK/T cell lymphoma, nasal type (ENKL) primarily involves the nasal cavity. Although patients might visit an otorhinolaryngologist with nasal symptoms, such as nasal obstruction and epistaxis, it would be difficult to make a diagnosis correctly. We present a case of ENKL in which the patie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116688/ https://www.ncbi.nlm.nih.gov/pubmed/35602784 http://dx.doi.org/10.7759/cureus.24177 |
_version_ | 1784710164259012608 |
---|---|
author | Kawaura, Ryo Ohnishi, Masami Hori, Tomoya |
author_facet | Kawaura, Ryo Ohnishi, Masami Hori, Tomoya |
author_sort | Kawaura, Ryo |
collection | PubMed |
description | Extranodal NK/T cell lymphoma, nasal type (ENKL) primarily involves the nasal cavity. Although patients might visit an otorhinolaryngologist with nasal symptoms, such as nasal obstruction and epistaxis, it would be difficult to make a diagnosis correctly. We present a case of ENKL in which the patient had been in remission after initial treatment and relapsed 14 years after treatment. The patient had a worsening of nasal symptoms before the recurrence, but on this occasion, treatment such as sinusitis was successful in alleviating the symptoms. Although recurrence of lymphoma 10 years after treatment is rare, the possibility of recurrence should always be considered in post-malignant lymphoma cases as with any malignant tumor. |
format | Online Article Text |
id | pubmed-9116688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-91166882022-05-20 Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type Kawaura, Ryo Ohnishi, Masami Hori, Tomoya Cureus Otolaryngology Extranodal NK/T cell lymphoma, nasal type (ENKL) primarily involves the nasal cavity. Although patients might visit an otorhinolaryngologist with nasal symptoms, such as nasal obstruction and epistaxis, it would be difficult to make a diagnosis correctly. We present a case of ENKL in which the patient had been in remission after initial treatment and relapsed 14 years after treatment. The patient had a worsening of nasal symptoms before the recurrence, but on this occasion, treatment such as sinusitis was successful in alleviating the symptoms. Although recurrence of lymphoma 10 years after treatment is rare, the possibility of recurrence should always be considered in post-malignant lymphoma cases as with any malignant tumor. Cureus 2022-04-16 /pmc/articles/PMC9116688/ /pubmed/35602784 http://dx.doi.org/10.7759/cureus.24177 Text en Copyright © 2022, Kawaura et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Otolaryngology Kawaura, Ryo Ohnishi, Masami Hori, Tomoya Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type |
title | Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type |
title_full | Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type |
title_fullStr | Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type |
title_full_unstemmed | Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type |
title_short | Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type |
title_sort | recurrence 14 years after initial treatment of extranodal nk/t cell lymphoma, nasal type |
topic | Otolaryngology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116688/ https://www.ncbi.nlm.nih.gov/pubmed/35602784 http://dx.doi.org/10.7759/cureus.24177 |
work_keys_str_mv | AT kawauraryo recurrence14yearsafterinitialtreatmentofextranodalnktcelllymphomanasaltype AT ohnishimasami recurrence14yearsafterinitialtreatmentofextranodalnktcelllymphomanasaltype AT horitomoya recurrence14yearsafterinitialtreatmentofextranodalnktcelllymphomanasaltype |